MedPath
NMPA Approval

Dopamine Hydrochloride Injection

国药准字H20243214

February 23, 2024

Drug Information

盐酸多巴胺注射液

注射剂

2.5ml:50mg

化学药品

February 23, 2024

Company Information

Applicant Company

福建省厦门市海沧区翁角西路2050号厦门生物医药产业园B1号楼第9层03单元

Manufacturing Company

河南省新郑市庆安路227号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸多巴胺注射液 - NMPA 批准文号 | MedPath